5 Results for "

arterial vasodilating

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "arterial vasodilating" in MCE Product Catalog:

Cat. No.: HY-122365
CAS No.: 6556-11-2
Purity:  98.00%
Synonyms: Inositol niacinate; Hexanicit
Inositol nicotinate (Hexanicit) has vasodilating effects and can be used in research on peripheral arterial disease, showing efficacy when taken orally. Inositol nicotinate does not significantly improve triglyceride levels in mice induced by biphenyl esters .
loading...
    loading...
Cat. No.: HY-P1556
CAS No.: 141676-35-9
Target:  

PKG

Research Areas:  

Cardiovascular Disease

Vasonatrin Peptide (VNP) is a chimera of atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP). Vasonatrin peptide possesses the venodilating actions of CNP, the natriuretic actions of ANP, and unique arterial vasodilating actions not associated with either ANP or CNP. Vasonatrin Peptide protects the diabetic heart against ischemia-reperfusion injury by inhibiting ER stress via the cGMP-PKG signaling pathway .
loading...
    loading...
Cat. No.: HY-113547
CAS No.: 102791-47-9
Synonyms: UK 61260
Research Areas:  

Cardiovascular Disease

Nanterinone (UK 61260) is a positive inotropic and arterial vasodilating agent. Nanterinone is a phosphodiesterase inhibitor .
loading...
    loading...
Cat. No.: HY-P1556A
Target:  

PKG

Research Areas:  

Metabolic Disease

Vasonatrin Peptide (VNP) TFA is a chimera of atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP). Vasonatrin peptide TFA possesses the venodilating actions of CNP, the natriuretic actions of ANP, and unique arterial vasodilating actions not associated with either ANP or CNP. Vasonatrin Peptide TFA protects the diabetic heart against ischemia-reperfusion injury by inhibiting ER stress via the cGMP-PKG signaling pathway .
loading...
    loading...
Cat. No.: HY-129706
CAS No.: 57184-68-6
Target:  

Others

Research Areas:  

Cardiovascular Disease

LY127210 free base is an orally active peripheral arterial vasodilating antihypertensive agent. LY127210 free base interferes with the baroreflex mechanism, exerts direct myocardial bradycardic activity, has no α or β receptor blocking properties, and acts via all conventional administration routes. LY127210 free base reduces vascular resistance, cardiac output, heart rate, left ventricular end-diastolic pressure, regional vascular resistance, as well as blood flow in the skin and cerebral cortex. LY127210 free base can be used in research related to hypertension .
loading...
    loading...